TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
BioNordika (Sweden) AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 60,329 | 53,730 | 57,065 |
Financial expenses | 0 | 0 | 2 |
Earnings before taxes | 6,378 | 7,277 | 10,184 |
EBITDA | 6,402 | 7,524 | 10,445 |
Total assets | 15,531 | 20,065 | 23,182 |
Current assets | 13,835 | 19,351 | 22,594 |
Current liabilities | 10,395 | 15,189 | 18,318 |
Equity capital | 5,136 | 4,876 | 4,864 |
- share capital | 100 | 100 | 100 |
Employees (average) | 14 | 13 | 12 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 33.1% | 24.3% | 21.0% |
Turnover per employee | 4,309 | 4,133 | 4,755 |
Profit as a percentage of turnover | 10.6% | 13.5% | 17.8% |
Return on assets (ROA) | 41.1% | 36.3% | 43.9% |
Current ratio | 133.1% | 127.4% | 123.3% |
Return on equity (ROE) | 124.2% | 149.2% | 209.4% |
Change turnover | 6,599 | -3,335 | 2,577 |
Change turnover % | 12% | -6% | 5% |
Chg. No. of employees | 1 | 1 | 2 |
Chg. No. of employees % | 8% | 8% | 20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.